47th week of 2011 patent applcation highlights part 48 |
Patent application number | Title | Published |
20110288137 | SYDNONIMINES-SPECIFIC DOPAMINE REUPTAKE INHIBITORS AD THEIR USE IN TREATING DOPAMINE RELATED DISORDERS - Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake. | 2011-11-24 |
20110288138 | ORALLY DISINTEGRATING TABLETS OF ZOLMITRIPTAN AND PROCESS FOR PREPARING THE SAME - Silicon dioxide free orally disintegrating tablet formulations of zolmitriptan or a pharmaceutically acceptable salt thereof having magnesium carbonate heavy and sodium stearyl fumarate with one or more pharmaceutically acceptable excipients and a process for preparing such a formulation and its use in the treatment of migraines. | 2011-11-24 |
20110288139 | SUBSTITUTED AMINO-BENZIMIDAZOLES, MEDICAMENTS COMPRIMISING SAID COMPOUND, THEIR USE AND THEIR METHOD OF MANUFACTURE - The present invention relates to substituted amino-benzimidazoles of general formula (1) wherein the groups R | 2011-11-24 |
20110288140 | TREATING INFLAMMATION AND INFLAMMATORY PAIN IN MUCOSA USING MUCOSAL PROLONGED RELEASE BIOADHESIVE THERAPEUTIC CARRIERS - The present invention concerns a pharmaceutical composition comprising an alpha-2 adrenergic receptor agonist for preventing or treating inflammatory pain and diseases in mucosa of oral cavity, pharynx and larynx. Inanother aspect the present invention provides mucosal bioadhesive slow release carriers for the extended and controlled release of alpha-2 adrenergic receptor agonists that can be used on mucosal surfaces for preventing or treating inflammatory pain and diseases in mucosa of oral cavity. | 2011-11-24 |
20110288141 | LOCAL TOPICAL ADMINISTRATION FORMULATIONS CONTAINING FIPRONIL - The present invention provides formulations and methods useful in eradicating ectoparasites on a domestic animal, decreasing the number of ectoparasites on a domestic animal, and/or preventing ectoparasite infestation on a domestic animal, using a local topical formulation comprising fiproniland a veterinarily acceptable carrier. | 2011-11-24 |
20110288142 | CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride - An improved AKT inhibiting compound, crystalline N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride. | 2011-11-24 |
20110288143 | BLADDER CANCER TREATMENT AND METHODS - Therapeutic compositions comprising an indoloquinone compound and various bladder cancer treatments and methods are disclosed. More specifically, the compositions comprise an indoloquinone compound and a formulation vehicle. The formulation vehicle improves the solubility and stability of the indoloquinone compound. Additionally, the coating compositions can include coating agents that provide better adhesion of the coating composition to the bladder wall during intravesical delivery of the coating composition. | 2011-11-24 |
20110288144 | USE OF HDAC INHIBITORS FOR THE TREATMENT OF MELANOMA - The invention relates to the use of an HDAC inhibitor, more specifically or a pharmaceutically acceptable salt thereof for the manufacture of pharmaceutical compositions for the treatment of melanoma; the use of an HDAC inhibitor or a pharmaceutically acceptable salt thereof in the treatment of melanoma; a method of treating warm-blooded animals including mammals, especially humans, suffering from melanoma by administering to a said animal in need of such treatment a dose effective against said disease of an HDAC inhibitor or a pharmaceutically acceptable salt thereof. | 2011-11-24 |
20110288145 | Novel Formulation For L-Tryptophane Comprising Carbidopa/Benserazide - The present invention relates to the use of L-tryptophan and a peripheral degradation inhibitor of L-tryptophan for the manufacture of a medicament for prevention or therapy of pain, depressions, sleeping disorders and other serotonin dependent diseases of the CNS, wherein L-tryptophan is present in a retarded and the peripheral degradation inhibitor is present in a non-retarded formulation. | 2011-11-24 |
20110288146 | DIRECTLY COMPRESSIBLE GRANULAR MICROCRYSTALLINE CELLULOSE BASED, EXCIPIENT, MANUFACTURING PROCESS AND USE THEREOF - An improved excipient comprising substantially homogeneous particles of a compressible, high functionality granular microcrystalline cellulose based excipient is provided. The improved excipient comprises microcrystalline cellulose and a binder, and optionally a disintegrant, and is formed by spraying a homogeneous slurry of the components. The excipient provides enhanced flowability/good flow properties, excellent/high compactibility, and increased API loading and blendability as compared to the individual components, and as compared to conventional excipients formed from the same materials. The improved excipient has strong intraparticle bonding bridges between the components, resulting in a unique structural morphology including significant open structures or hollow pores. The presence of these pores provides a surface roughness that is the ideal environment for improved blending with an API. | 2011-11-24 |
20110288147 | Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop - The invention features compositions and methods that are useful for reducing the expression or activity of a specified gene in a eukaryotic cell. | 2011-11-24 |
20110288148 | TRIGGERED COVALENT PROBES FOR IMAGING AND SILENCING GENETIC EXPRESSION - The present invention relates to the use of cross-linking probes to covalently bind probes to nucleic acid targets. In some embodiments, the probe comprises an initiator region that is able to bind to a first portion of a target nucleic acid, a probe region linked too the initiator region that is able to bind to a second region of the target nucleic acid and that comprises one or more cross-linkers, and a blocking region hybridized to the probe region. | 2011-11-24 |
20110288149 | Method of protecting against heart failure - The present invention relates, in general, to heart failure, and, in particular to a method of reducing the risk of heart failure, particularly in patents with established cardiomyopathy. | 2011-11-24 |
20110288150 | Oligonucleotides for Suppressing Cancer Cell Invasion and Migration - Provided herein is a method for detection of migratory and invasive cancer cells based on a number of marker nucleic acids differentially expressed in migratory/invasive cancer cells relative to nonmigratory/noninvasive cancer cells. Also disclosed are antisense oligonucleotides of the marker nucleic acids and uses thereof for suppressing cancer cell migration and invasion. | 2011-11-24 |
20110288151 | METHODS OF CHARACTERIZING BREAST CANCER AND IDENTIFYING TREATMENTS FOR SAME - This application describes antibodies to P-Rex 1, and methods of detecting breast cancer, and methods of treatments for the same. | 2011-11-24 |
20110288152 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING - Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for targeting prostate cancer cells. Also described herein are compositions containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them. | 2011-11-24 |
20110288153 | TRANSLATION FACTORS AS ANTI-AGING DRUG TARGETS - In certain embodiments this invention pertains to the discovery that inhibition of the expression and/or activity of eukaryotic initiation factor 4A (eIF4A) inhibits the aging process. Accordingly, in certain embodiments, methods are provided for inhibiting/slowing aging. The methods typically involve administering to a mammal an agent that inhibits the expression and/or activity of eukaryotic initiation factor 4A (eIF4A) in an amount sufficient to inhibit expression or activity of EIF4A, where the agent is not resveratrol. | 2011-11-24 |
20110288154 | RNA Interference Mediated Inhibition of Epithelial Sodium Channel (ENaC) Gene Expression Using Short Interfering Nucleic Acid (siNA) - The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of ENaC gene expression and/or activity, and/or modulate a ENaC gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against ENaC gene expression. | 2011-11-24 |
20110288155 | SIRNA COMPOUNDS AND METHODS OF USE THEREOF - The present application relates to double stranded oligonucleotide inhibitors of target genes, pharmaceutical compositions comprising same and the use of such molecules to treat, inter alia, neurodegenerative disorders including Alzheimer's disease and Amyotrophic Lateral Sclerosis, eye diseases including glaucoma and ION, acute renal failure, hearing loss, acute respiratory distress syndrome and in preventing or treating ischemia-reperfusion injury in organ transplant patients. | 2011-11-24 |
20110288156 | Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis - The present invention relates to isolated and/or purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase (DHS) nucleic acids and polypeptides. The present invention also relates to methods of modulating apoptosis using apoptosis-specific eIF-5A and DHS, and antisense oligonucleotides and expression vectors of apoptosis-specific and DHS useful in such methods. | 2011-11-24 |
20110288157 | RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions - RNA interference is provided for inhibition of spleen tyrosine kinase (Syk) mRNA expression, in particular, for treating patients having a Syk-related inflammatory condition or at risk of developing a Syk-related inflammatory condition such as allergic conjunctivitis, ocular inflammation, dermatitis, rhinitis, asthma, allergy, or mast-cell disease. | 2011-11-24 |
20110288158 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - The invention is directed to compositions and methods for selectively reducing the expression of a gene product from a desired target gene in a cell, as well as for treating diseases caused by the expression of the gene. More particularly, the invention is directed to compositions that contain double stranded RNA (“dsRNA”), and methods for preparing them, that are capable of reducing the expression of target genes in eukaryotic cells. The dsRNA has a first oligonucleotide sequence that is between 25 and about 30 nucleotides in length and a second oligonucleotide sequence that anneals to the first sequence under biological conditions. In addition, a region of one of the sequences of the dsRNA having a sequence length of at least 19 nucleotides is sufficiently complementary to a nucleotide sequence of the RNA produced from the target gene to trigger the destruction of the target RNA by the RNAi machinery. | 2011-11-24 |
20110288159 | METHODS OF EXPRESSING A POLYPEPTIDE IN THE BRAIN AND NUCLEIC ACID CONSTRUCTS CAPABLE OF SAME - A nucleic acid construct and construct system are disclosed. The nucleic acid construct and system comprise a regulatory sequence which regulates inducible expression of a polypeptide of interest, the regulatory sequence comprising a choroid plexus specific promoter, with the proviso that the choroid plexus specific promoter is not a transthyretin promoter. Pharmaceutical compositions comprising same and uses thereof are also disclosed. | 2011-11-24 |
20110288160 | Treatment of Metabolic-Related Disorders Using Hypothalamic Gene Transfer of BDNF and Compositions Therefor - Described herein is a system which uses a gene therapy particle that includes at least one gene, cDNA, fragment or analogue of at least one neurotropin that binds to the trkB receptor or the trkB receptor itself. The gene therapy particle is capable of being delivered to a subject in need thereof for therapy of a metabolic disorder. In a particular aspect, this invention is directed to an inventive method that demonstrates a remarkable efficacy on lowering body weight. | 2011-11-24 |
20110288161 | METHODS FOR TREATMENT OF THIOL-CONTAINING COMPOUND DEFICIENT CONDITIONS - Certain embodiments in the present invention provide for methods for therapy of lung diseases and other conditions such as infection are provided. In certain embodiments, the methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system (i.e., ABC transporters such as MDR-1 or MRP-2) in cells. Other embodiments can include the use of agents to modulate transport of thiol-containing compounds from the cell such as thiocyanate. In certain embodiments, therapeutic methods involve the administration of such agents to a patient afflicted with an inflammatory condition or infection responsive to stimulation of thiol-containing compound transport. | 2011-11-24 |
20110288162 | TRANSITION METAL COMPLEXES OF A BIS[THIO-HYDRAZIDE AMIDE] COMPOUNDS - The present invention is directed to a compound comprising a bis[thiohydrazide amide] or a deprotonated form thereof, complexed to a transition metal cation, wherein the bis[thio-hydrazide amide] is represented by Structural Formula (I): or a prodrug, isomer, ester, salt, hydrate, solvate, polymorph or a deprotonated form thereof. The present invention also provides a pharmaceutical composition comprising a compound of the invention and method of use thereof. | 2011-11-24 |
20110288163 | METHODS OF USING MACROCYCLIC MODULATORS OF THE GHRELIN RECEPTOR - The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and variants thereof). Methods of synthesizing the novel compounds are also described herein. These compounds are useful as agonists of the ghrelin receptor and as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, gastrointestinal disorders, cardiovascular disorders, obesity and obesity-associated disorders, central nervous system disorders, genetic disorders, hyperproliferative disorders and inflammatory disorders. | 2011-11-24 |
20110288164 | AGENT FOR INHIBITING PRODUCTION OF HEPATITIS C VIRUS AND ITS USE - This invention provides an agent for inhibiting production of hepatitis C virus with notable anti-HCV activity and without side-effects. The agent comprises a proanthocyanidin polymer composition illustrated in the following the general formula (1), | 2011-11-24 |
20110288165 | NOVEL LIPID COMPOSITION FOR THE TREATMENT OF SKIN PROBLEMS IN COMPANION ANIMALS - The present invention provides lipid compositions comprising linolenic acid (LA), alpha-linolenic acid (ALA), stearidonic acid (SDA) and gamma linolenic acid (GLA), said LA and ALA in a ratio of about less than 2:1 LA:ALA. The compositions find use in for improving, treating, or preventing a condition selected from the group consisting of: eczema, dry skin, flaky skin, pruritus, pyotraumatic dermatitis, furunculosis, dry paw pads, rough paw pads, chapped paw pads, paw pad durability, dry rhinarium, chapped rhinarium, split claws, brittle claws, rashes, hairless spots, hot spots, symmetrical lupoid onychodystrophy, skin ulceration, skin crusting, reddening of skin between toes, external ear infection, and nutritional dermatosis. | 2011-11-24 |
20110288166 | TRIPTOLIDE C-RING DERIVATIVES AS ANTICANCER AGENTS AND IMMUNE MODULATORS - Disclosed are compounds based on C- and D-ring modifications of triptolide and hydroxylated triptolide, for use in therapy, such as antiproliferative, anticancer, and immunosuppressive therapy. | 2011-11-24 |
20110288167 | Butylphthalide Intravenous Emulsion and Application Thereof - The present invention discloses a butylphthalide intravenous emulsion for intravenous injection or infusion, containing butylphthalide or derivatives thereof as an active ingredient in an amount of 0.01˜50 wt % and an excipient in an amount of 50˜99.99 wt %, based on the total weight of the emulsion. | 2011-11-24 |
20110288168 | HISTONE DEACETYLASE INHIBITORS - Histone deacetylase is a metallo-enzyme with zinc at the active site. Compounds having a zinc-binding moiety, such as, for example, a hydroxamic acid group or a carboxylic acid group, can inhibit histone deacetylase. Histone deacetylase inhibition can repress gene expression, including expression of genes related to tumor suppression. Accordingly, inhibition of histone deacetylase can provide an alternate route for treating cancer, hematological disorders, e.g., hemoglobinopathies, genetic disorders, e.g. Huntington's disease and spinal muscular atrophy and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy. | 2011-11-24 |
20110288169 | TRITERPENOID COMPOUNDS AND METHODS OF USE THEREOF - The present invention provides therapeutically active compounds and compositions as receptor antagonists and methods of use thereof. In one aspect, the compounds are useful in modulating pain, inflammation and acute phase reactions by inhibiting the PGE2 receptors including PGE2 EP1, EP2 and EP4 receptors. | 2011-11-24 |
20110288170 | RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS - Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided. | 2011-11-24 |
20110288171 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 2011-11-24 |
20110288172 | DERMATOLOGICAL COMPOSITIONS AND METHODS - Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid. | 2011-11-24 |
20110288173 | Use of neboglamine in the treatment of toxicodependency - Use of neboglamine, (S)-4-amino-N(4,4-dimethyl-cyclohexyl)glutamic acid (CR 2249) (CAS Registry Number 163000-63-3), the racemic mixture thereof or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the treatment of toxicodependency induced by drugs such as CNS sedatives such as opiates, barbiturates, benzodiazepines, alcohol, stimulants such as amphetamines and cocaine, and hallucinogens such as LSD, mescalin, cannabis (marijuana) or fencyclidine. | 2011-11-24 |
20110288174 | Monohydrate of 4-(phenyl)ethyl]-amino}methyl)benzoic acid - The invention relates to novel forms of 4-({(4-carboxybutyl) [2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]amino}methyl)benzoic acid, in particular to the monohydrate in form A, to processes for their preparation, to medicaments comprising them and to their use for fighting diseases. | 2011-11-24 |
20110288175 | 1-PHENYLALKANECARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - 1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease. | 2011-11-24 |
20110288176 | ETHACRYNIC ACID-CONTAINING COMPOSITION FOR PREVENTION OR TREATMENT OF TRANSGLUTAMINASE-RELATED DISEASES AND METHOD FOR PREVENTION OR TREATMENT OF TRANSGLUTAMINASE-RELATED DISEASES USING THE SAME - The present invention relates to ethacrynic acid and a transglutaminase inhibitor comprising a pharmaceutically acceptable salt of ethacrynic acid; more particularly, to ethacrynic acid for inhibiting the activity of transglutaminase involved in the pathogenesis of diseases in cases of altered expression, a transglutaminase inhibitor comprising a pharmaceutically acceptable salt of ethacrynic acid, and to a novel use of thereof. According to the present invention, there are provided ethacrynic acid, a transglutaminase inhibitor comprising active components of a pharmaceutically acceptable salt of ethacrynic acid and a transglutaminase inhibition method. The present ethacrynic acid, transglutaminase inhibitor comprising a pharmaceutically acceptable salt of ethacrynic acid or ethacrynic acid itself, and transglutaminase inhibition method provide a safer application without side effects to a patient having a disease where altered expression of transglutaminase is observed, thereby providing the inhibitory effect on transglutaminase. | 2011-11-24 |
20110288177 | Methods for Preventing or Reducing Colon Carcinogenesis - The present invention is directed in part to methods of preventing or reducing colon carcinogenesis comprising administering to a patient at risk of colorectal cancer, a pharmaceutical preparation comprising a chemopreventive agent disclosed herein. | 2011-11-24 |
20110288178 | RADIOPROTECTIVE AGENTS - Provided herein are methods, for reducing, preventing, mitigating and treating damage caused by radiation. The methods comprise delivering a compound, as described herein, to a patient in an amount and dosage regimen effective to prevent, mitigate or treat damage caused by radiation or to mitigate apoptosis. The compounds comprise glyburide or other sulfonylurea hypoglycemic compounds or potassium channel inhibitors. | 2011-11-24 |
20110288179 | BIMATOPROST CRYSTALLINE FORM I - The invention provides a novel polymorphic form I of crystalline bimatoprost, method for preparation thereof and new crystalline intermediates in the preparation. This form I of crystalline bimatoprost is used in purification of crude bimatoprost and in storage of bimatoprost as active pharmaceutical intermediate. Use of the physical form of bimatoprost in the manufacture of a medicament is also disclosed. | 2011-11-24 |
20110288180 | DIETARY PURGATIVES - Described are kits, food compositions and methods for cleaning the bowel, e.g., in preparation for a medical procedure, e.g., a diagnostic or treatment procedure, such as an endoscopic or surgical procedure, or radiologic imaging such as CT colography. | 2011-11-24 |
20110288181 | PREPARATIONS OF BIOLOGICALLY ACTIVE SUBSTANCES WITH ENLARGED SURFACE BASED ON AMPHIPHILIC COPOLYMERS - Preparations with enlarged surface comprising an active ingredient and an amphiphilc copolymer, wherein the copolymer comprises at least one polyether-containing graft polymer. The preparations are partially or completely foamed. Processes for producing the preparations are also described, including processes comprising extrusion of a melt impregnated with a physiologically acceptable volatile blowing agent. | 2011-11-24 |
20110288182 | HEALTH CHARACTERISTIC DULCE DE LECHE CONFECTION COMPOSITIONS AND FLAVORED MILK - The present invention provides for Dulce de Leche confection compositions and Dulce de Leche based flavored milk that has an improved, healthier fat structure, unique antioxidant taste profile, lower sugar content, fiber component, and a 0% or greater supplement component that can add additional dietary benefits. Cholesterol reduction can be accomplished within certain embodiments of this invention. Specific ratios of ingredients within our compositions create a taste, texture, mouth feel, and rich and creamy true Dulce de Leche confection without the negative health ramifications of high milk fat content and sugar content characteristic of traditional Dulce de Leche products. Additionally, the method for preparing these Dulce de Leche confection products and flavored milk are covered. | 2011-11-24 |
20110288183 | CHEMOMECHANICAL MANUFACTURE OF FUNCTIONAL COLLOIDS - A method for producing a functional colloid during which particles are reactively fragmented in a mechanical manner in a dispersant in the presence of a modifying agent so that the modifying agent is chemically bound, at least in part, to the fragmented colloid particles. | 2011-11-24 |
20110288184 | MODULAR PLANT FOR REMOVAL OF POLLUTANTS FROM FLUE GASES PRODUCED BV INDUSTRIAL PROCESSES - The invention relates to a so-called zero emission ‘AST-CNR/ITM system’ modular plant for removal of pollutants from flue gases produced by industrial processes. The plant comprises prefabricated modular elements with programmed and automatic operation, easy to mount and assemble on site without undergoing expensive plant stoppage. Each module or ‘reaction tower’ comprises a plurality of sections vertically arranged on top of one another, which carry out the following functions: Removal of particulate matter with treatment and removal of chemical pollutants, such as heavy metals, chlorides, fluorides Treatment and removal of SOx Treatment and removal of NOx Capture of CO | 2011-11-24 |
20110288185 | LARGE SCALE GREEN MANUFACTURING OF METHANE USING PLASMA - A method and system for converting waste using plasma into methane. The method uses minimal fossil fuel, and therefore produces a minimal carbon footprint when compared to conventional processes. The method includes the steps of supplying a biomass material to a plasma melter; supplying electrical energy to the plasma melter; supplying steam to the plasma melter; extracting a syngas from the plasma melter; extracting hydrogen from the syngas; and forming methane from the hydrogen produced in the step of extracting hydrogen. | 2011-11-24 |
20110288186 | METHOD FOR RECYCLING FT-WAX-CONTAINING IRON CATALYST REMOVED FROM A FISCHER-TROPSCH REACTOR - A method is disclosed for utilizing a waste product flow discharged from a Fisher-Tropsch reactor, the waste product chiefly consisting of spent catalyst and FT wax. The method is characterized in that waste flow, specifically containing iron catalyst and FT wax, discharged from the FT reactor is passed back to the gasification unit of the BtL process. | 2011-11-24 |
20110288187 | PROTON-CONDUCTING MEMBRANE AND THE USE OF THE SAME - The present invention relates to a novel proton-conducting polymer membrane based on polyazoles which can, because of its excellent chemical and thermal properties, be used in a variety of ways and is particularly useful as polymer electrolyte membrane (PEM) to produce membrane electrode units for PEM fuel cells. | 2011-11-24 |
20110288188 | PROCESSING OF WASTE MATERIAL - A method of processing waste carpet or matting material to separate constituent materials thereof, includes optionally drying the material and then cooling the material to a temperature at which at least one constituent material therein is embrittled. A mechanical force is applied to the cooled material causing the embrittled constituent material to break into fragments. Optionally, the material from the previous step is dried. The material is then separated to separate the fragments of constituent material from other constituent material. The carpet material can be initially shredded into coarse pieces. The procedure may be repeated optionally with different temperatures to selectively embrittle and fragment different components and facilitate their separation. | 2011-11-24 |
20110288189 | Textile Backing Formed From Recycled Materials - Backings for carpet and carpet tiles are formed from various post-consumer and/or post-industrial polymeric waste materials, for example, post-consumer textile waste material (e.g., carpet and carpet tiles), post-industrial textile waste material (e.g., carpet and/or carpet tiles), and/or other post-consumer and/or post-industrial polymeric materials. | 2011-11-24 |
20110288190 | METHOD FOR TREATING A MATERIAL DERIVED FROM RECOVERY AND GRINDING - A method of treating a material derived from recovery and shredding, the material comprising a mixture of polypropylene and polyethylene, wherein the material is mixed with 1% to 5% by weight of copolymer of ethylene-α-olefin type. | 2011-11-24 |
20110288191 | MACROPOROUS ABSORBENT RESIN FOR EXTRACTING CEPHALOSPORIN C AND METHOD OF PREPARATION - The invention relates to macroporous absorbent resin special for extracting cephalosporin C and process for preparation. Specific surface area of such kinds of adsorbent resins is around 1000-2000 m | 2011-11-24 |
20110288192 | TETRAFLUOROPROPENE BASED BLOWING AGENT COMPOSITIONS - The present invention relates to blowing agent compositions comprising tetrafluoropropene (HFO) and at least one co-blowing agent selected from carbon dioxide, water, alkanes and an alcohol used in the preparation of foamable thermoplastic compositions having low density. The HFOs include, but are not limited too, cis- and/or trans-1,3,3,3-tetrafluoropropene (HFO-1234ze), 2,3,3,3-tetrafluoropropene (HFO 1234yf), or mixtures thereof. The blowing agent compositions are useful in the production of low density insulating foams with improved R value. | 2011-11-24 |
20110288193 | Method for Producing Moulded Parts Containing Polybutadiene - The present invention relates to a novel process for the production of polybutadiene-containing mouldings. | 2011-11-24 |
20110288194 | POLYAMIDE AND BIORESOURCED REINFORCEMENT COMPOSITIONS HAVING IMPROVED MECHANICAL PROPERTIES - One subject of the present invention is a composition that combines at least one polyamide having at least one MXD entity, MXD denoting meta-xylylenediamine or a mixture of meta-xylylenediamine and of para-xylylenediamine, with a bioresourced reinforcement. The invention also relates to the conversion of these compositions, by injection moulding or extrusion, into objects that have good mechanical properties, said objects corresponding to technical application specifications such as may be found, for example, in the automotive industry, construction, sport and in electrical or electronic fields. | 2011-11-24 |
20110288195 | DENTAL FILLING/RESTORATION KIT - Provided is a filling/restoring material, including a photopolymerization initiator of a quaternary system formed by combining an α-diketone compound, an aliphatic amine compound, an aromatic amine compound, and a photoacid generator, in which even when the filling/restoring material is filled and cured on a cured layer of a dental adhesive material including a radical-polymerizable monomer having an acidic group, the filling/restoring material undergoes sufficient curing up to a contact interface between the filling/restoring material and the cured layer, thereby providing high adhesive strength stably. Also provided is a dental filling/restoration kit, including: a filling/restoring material including: a polymerizable monomer having no acidic group; a basic inorganic material; and a photopolymerization initiator formed by at least combining: an α-diketone compound; an aliphatic amine compound; an aromatic amine compound; and a photoacid generator; and an adhesive material, which is used for adhesion between a tooth and the filling/restoring material by curing the adhesive material before filling the filling/restoring material, the adhesive material including: a polymerizable monomer including a polymerizable monomer having an acidic group; and a polymerization initiator. | 2011-11-24 |
20110288196 | DENTAL COMPOSITIONS COMPRISING BISACRYLAMIDES AND USE THEREOFE - The invention concerns a dental composition comprising bisacrylamides that are polymerizable by free-radical polymerization and by Michael-addition polymerization with amines. The application of polymerization and addition polymerization with amines opens the possibility to completely reacted materials that have no oxygen inhibited layers. The claimed bisacrylamides have an improved hydrolytic stability. | 2011-11-24 |
20110288197 | UV-CURABLE POLYMER THICK FILM DIELECTRIC COMPOSITIONS WITH EXCELLENT ADHESION TO ITO - This invention provides a screen printable dielectric composition comprising finely divided particles of talc dispersed in a curable liquid composition containing an acrylated urethane resin oligomer, an alkyl acrylate, and phosphoric acid. | 2011-11-24 |
20110288198 | UV CURABLE INK FOR A PLASTIC GAZING SYSTEM - A UV curable printing ink system suitable for printing a decorative marking and/or opaque border, preferably used in the manufacture of an automotive plastic glazing panel, is described. | 2011-11-24 |
20110288199 | Fiber-Hydrogel Composite for Tissue Replacement - The present invention includes tailored fiber-reinforced hydrogel composites for implantation into a subject. The present invention also includes systems and methods for controlling the relative percent volume of the hydrogel and fibers, cross-linking, fiber orientation, weave and density, such that the material properties of the composite can be controlled and/or customized to match particular tissue types. The composites of the present invention are suitable for repairing or replacing musculoskeletal tissues and/or fibrocartilage, such as the meniscus, ligaments and tendons. | 2011-11-24 |
20110288200 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS - A method for preparing a functionalized polymer, the method comprising the steps of polymerizing monomer to form a reactive polymer, and reacting the reactive polymer with a polycyano compound. | 2011-11-24 |
20110288201 | POWDER COATING COMPOSITION - A masterbatch composition, a method for the preparation of a masterbatch composition, a method for the preparation of a powder coating composition, a powder coating composition obtainable by said method as well as the use of a masterbatch composition for a powder coating composition or for increasing the opacity of a cured powder coating is disclosed. | 2011-11-24 |
20110288202 | HEAT-CURING POWDER-LACQUER COMPOSITIONS YIELDING A MATTE SURFACE AFTER CURING OF THE COATING, AS WELL AS A SIMPLE METHOD FOR PRODUCTION OF SAME - The invention relates to heat-curing powder-lacquer compositions exhibiting a matte surface after curing of the coating, as well as to a simple method for production of the same. | 2011-11-24 |
20110288203 | FIRE RESISTANT MATERIAL AND FORMULATION THEREOF - The invention provides a fire resistant material and a formulation thereof. The formulation comprises a liquid suspension of a modified inorganic particle and an organic component. The modified inorganic particle comprises an inorganic particle with hydroxyl groups and a surface modifier coupled to the inorganic particle via a urethane linkage, wherein the surface modifier has an ethylenically unsaturated end group. The organic component comprises a monomer, oligomer, prepolymer, polymer, or combinations thereof, capable of reacting with the ethylenically unsaturated end group. | 2011-11-24 |
20110288204 | FUNCTIONALIZED POLYURETHANE POLYUREA DISPERSIONS - The present invention relates to aqueous polyurethane urea dispersions having integral functional groups and coating agents produced therefrom, to a method for the production thereof, and to the use thereof for producing coating agents. | 2011-11-24 |
20110288205 | POLYMER DISPERSIONS OF NARROW PARTICLE SIZE DISTRIBUTION - A process for the manufacture of a polymer dispersion comprising the steps of i) providing a mixture comprising from 2 to 60 parts by weight of a first polypropylene polymer having sufficient carboxylic acid and/or carboxylic acid anhydride groups equivalent to an acid value of from 2 to 50 mg KOH/g nv polymer and from 40 to 98 parts by weight of a second polymer having a molar excess of functional groups capable of reacting with the carboxylic acid and/or carboxylic acid anhydride groups of the polypropylene ii) causing the polymers to melt at a chosen temperature under conditions of high shear in an extruder to form an intimate mixture of the polymers iii) causing some of the carboxylic acid and/or carboxylic acid anhydride groups of the polypropylene to react with at least some of the functional groups of the second polymer to form a reaction mixture, under conditions of high shear in an extruder iv) rapidly cooling the reaction mixture outside the extruder to form a solid product v) optionally breaking up the solid product into smaller pieces vi) contacting the solid product with an organic liquid wherein the organic liquid is chosen to be a good solvent for the second polymer and a poor solvent for the polypropylene polymer whereby a dispersion comprising polypropylene particles in a solution of the second polymer dissolved in the organic liquid is formed. | 2011-11-24 |
20110288206 | MELAMINE PHENYLPHOSPHINATE FLAME RETARDANT COMPOSITIONS - The present invention relates to flame retardant polymer compositions which comprise melamine phenylphosphinates and mixtures with dihydro-oxa-phosphaphenanthrene derivatives. The compositions are especially useful for the manufacture of flame retardant compounds based on polyfunctional epoxides or polycondensates like polyesters, polyamides and polycarbonates. | 2011-11-24 |
20110288207 | BIOMASS-RESOURCE-DERIVED POLYESTER AND PRODUCTION PROCESS THEREOF - The present invention provides a resin capable of contributing greatly to solve environmental problems and problems related to exhaustion of fossil fuel resources and having physical properties suited for practical use. | 2011-11-24 |
20110288208 | MODIFIER FOR RESINS, ADHESIVE COMPOSITIONS, AND THERMOPLASTIC RESIN COMPOSITIONS - The present invention provides a resin modifier comprising as an active ingredient a hydrogenated rosin ester in which a component having a molecular weight of 320 of a methylation product of a hydrolyzate of the hydrogenated rosin ester as measured by gas chromatography-mass spectrometry accounts for 95 wt % or greater of the total amount of the components having a molecular weight of 314 to 320; a modifier that is an optical embrittlement inhibitor for use in an adhesive polymer resin; an adhesive composition comprising the optical embrittlement inhibitor; a modifier that is a melt fluidity and adhesion improver for a thermoplastic resin; and a thermoplastic resin composition comprising the melt fluidity and adhesion improver. | 2011-11-24 |
20110288209 | Easily Dispersible Solid Pigment Preparations - The present invention relates to solid pigment preparations containing (A) 5 to 99 percent by weight of at least one pigment; (B) 1 to 95 percent by weight of at least one water-soluble dispersing additive based on copolymers that consist of the following structural units: (i) 1.0 to 50 mol percent of structural unit B1; a combined total of 50 to 99.0 mole percent of structural units (B2) and (B3); (iii) 0 to 49 mole percent of structural unit (B4). | 2011-11-24 |
20110288210 | Mesoporous Silicate Fire Retardant Compositions - Fire retardant or flame retardant additives are incorporated into thermoplastic, thermoset, and/or elastomeric polymer materials to form polymer compositions having improved fire retardant properties. More particularly, the polymer compositions of the present invention comprise additive compositions which have the effect of improving the FR effectiveness, the additive compositions comprising a mesoporous silicate additive. In addition, the polymer compositions of the present invention comprise additive compositions comprising a mesoporous silicate additive and a filler, wherein the filler is a flame retardant addition, an inert filler, or combinations thereof. | 2011-11-24 |
20110288211 | AQUEOUS COATING AGENT - An aqueous coating material for use in an in-mold coating process in which a coating material is applied to an inner wall of a cavity within a mold to form a coated film, and a filler material is then injected into a gap between this coated film and an object to be treated, thereby forming a coating of the filler material on the surface of the object to be treated, with the coated film being formed as the outermost layer. Wherein the aqueous coating material includes water and a film forming aid, such that 10 g of the aqueous coating material placed in an acrylic pipe having a height of 1 m and an inner diameter of 34 mm and a pressure in the acrylic pipe is reduced to form a foam, the foam rises to a height that is at least 400 mm. | 2011-11-24 |
20110288212 | INKJET INK INCLUDING POLYURETHANE - An inkjet ink composition includes: from 0.25 to 6 weight percent colorant; from 7 to 40 weight percent solvent; from 0.05 to 5 weight percent surfactant; and polyurethane binder in an amount of at least 0.5 weight percent of the inkjet ink composition but not more than twice the weight percent of the colorant. The polyurethane binder has a molecular weight from 32 K to 50 K and an acid number from 40 to 45. The polyurethane binder includes polyether polyol, aliphatic isocyanate and an acid group and does not include chain extenders. | 2011-11-24 |
20110288213 | MULTIMODAL POLYMER OF PROPYLENE, COMPOSITION CONTAINING THE SAME AND A PROCESS FOR MANUFACTURING THE SAME - The present invention aims to provide a multimodal polymer of propylene comprising a matrix of semicrystalline polymer and a rubber (D) dispersed in said matrix, the multimodal polymer comprising units derived from propylene of from 85 to 99% by weight and units derived from ethylene or C | 2011-11-24 |
20110288214 | POLYSILOXANE-POLYCARBONATE COMPOSITIONS, METHOD OF MANUFACTURE, AND ARTICLES FORMED THEREFROM - A composition, comprising, based on the total weight of the polymer components in the composition, 1 to 40 wt. % of an aromatic polycarbonate, 30 to 98.8 wt. % of a polysiloxane-polycarbonate block copolymer, and 0.1 to 10 wt. % of a polysiloxane-polyimide block copolymer comprising more than 20 wt. % polysiloxane blocks, based on the total weight of the polysiloxane-polyimide copolymer. The compositions provide articles with low haze, high luminous transmittance, and good hydro-aging properties. The articles can further be formulated to have excellent flame retardance, particularly when KSS is used. | 2011-11-24 |
20110288215 | SURFACE-MODIFIED ZIRCONIA NANOPARTICLES - Surface-modified zirconia nanoparticles and methods for making and using the same are provided. The surface-modifiers include non-metallic organic derivatives, comprising at least one hydroxamate functionality, wherein at least some of the non-metallic organic derivatives are attached to at least some of the zirconia nanoparticles. | 2011-11-24 |
20110288216 | POLYOLEFIN-BASED RESIN COMPOSITION FOR FOOD, MEDICAL, AND MUNICIPAL WATER PIPE APPLICATIONS - The present invention provides a stabilized polyolefin-based resin composition for use in food items, medical services and water service pipes, which has superior non-migratory and hygienic properties. | 2011-11-24 |
20110288217 | COATINGS WHICH ARE BASED ON ALLOPHANATE GROUP-CONTAINING POLYISOCYANATES - The invention relates to coating systems for producing fast-drying coatings which are based on aromatic allophanate group-containing prepolymers and aliphatic polyisocyanates and aminofunctional compounds as the curing agents. | 2011-11-24 |
20110288218 | VINYL CHLORIDE RESIN COMPOSITION - Provided is a vinyl chloride resin composition having superior heat resistance, colorability and processability without using a heavy metal stabilizer such as lead. | 2011-11-24 |
20110288219 | METHOD FOR FORMING COMPOSITE MATERIALS - Disclosed is layered double hydroxides (LDH) used to catalyze the polymerization of polyethylene terephthalate (PET). The LDH of a catalyst amount may efficiently reduce the PET polymerization period and further be uniformly blended into the PET product to form composites. Compared with the pure PET, the composite including LDH has better properties such as mechanical properties, linear expansion coefficient, barrier, thermal stability, and transparency. In addition, the LDH in the composite is safer than conventional heavy metal catalysts, especially when applied to food or drink packages. | 2011-11-24 |
20110288220 | LASER-TRANSPARENT POLYESTERS - Use of thermoplastic molding compositions comprising, as essential components,
| 2011-11-24 |
20110288221 | POLYMER PROCESSING ADDITIVE AND MOLDING COMPOSITION - The invention provides a polymer processing additive which, when added to a melt-processable resin, is highly effective in improving the moldability of the resin, and a molding composition containing the polymer processing additive, among others. This invention is related to a polymer processing additive comprising a fluoroelastomer subjected to heat treatment with an alkali metal inorganic salt or alkaline earth metal inorganic salt added thereto. | 2011-11-24 |
20110288222 | OPTICAL RESIN COMPOSITION AND METHOD FOR PRODUCING THE SAME - To provide an optical resin composition containing carbonate crystals, which have oriented birefringence, have a needle- or rod-like shape, and are able to negate the birefringence without sacrificing the light transmittance of a transparent polymeric resin where the carbonate crystal exists, and a method for producing the resin composition. To achieve this provided are an optical resin composition containing a resin and carbonate crystals, wherein the carbonate crystals have a specific surface area of 4 m | 2011-11-24 |
20110288223 | Supercritical Carbon-Dioxide Processed Biodegradable Polymer Nanocomposites - A biodegradable film and a method of forming a biodegradable film are provided. In one aspect, the biodegradable film includes a reinforced biodegradable polymer including a biodegradable polymer and a reinforcing agent substantially dispersed throughout the biodegradable polymer by rapid depressurization of a supercritical fluid wherein the reinforced biodegradable polymer is formed into the film. | 2011-11-24 |
20110288224 | Polymeric Matrix Nanocomposite Materials Having Improved Mechanical and Barrier Properties and Procedure For Preparing Same - The present invention relates to nanocomposite materials based on a polymeric or plastic matrix and a laminar silicate (clay) having improved mechanical, thermal and gas-barrier properties, among others, and not requiring clay-matrix compatibilising agents. Furthermore the present invention relates to three procedures for the obtainment of these materials and use thereof for applications such as in packaging products of interest to the food sector, among others, and for applications in other sectors. | 2011-11-24 |
20110288225 | Preparation and Provision of High Assay Decabromodiphenylethane - High assay, reaction-derived decabromodiphenylethane product is prepared by feeding (i) diphenylethane or (ii) partially brominated diphenylethane having an average bromine number less than about two, or (iii) both of (i) and (ii), into the liquid confines of a reaction mixture. Such reaction mixture is (a) formed from components comprised of excess liquid bromine and aluminum-based Lewis acid bromination catalyst, and (b) maintained at one or more elevated reaction temperatures of from about 45°-90° C., and at least when elevated pressure is needed to keep a liquid state in the reaction mixture at the temperature(s) used, the reaction mixture is at such an elevated pressure, whereby ar-bromination occurs. The feeding is conducted at a rate slow enough to form high assay reaction-derived decabromodiphenylethane product, which is an effective flame retardant. | 2011-11-24 |
20110288226 | Compounded masterbatch for carrying flame retardant materials and processer for preparing - Compounded masterbatch compositions for carrying fire retardant materials and novel processes for preparing such masterbatch compositions. | 2011-11-24 |
20110288227 | POLYMERIZABLE IONIC LIQUID COMPOSITIONS - The compositions comprise an acid functional monomer or acid-functional copolymer (or conjugate base thereof), and an imidazole compound (or conjugate acid thereof). | 2011-11-24 |
20110288228 | Ink for Marking - An ink for marking which is used for marking an outer surface of an article having at least the outer surface formed of a resin and which is excellent in friction resistance and flex resistance after marking is provided. | 2011-11-24 |
20110288229 | Vinyl alcohol copolymers for use in aqueous dispersions and melt extruded articles - A sulfonic acid-functionalized vinyl alcohol copolymer is provided which is characterized by a substantial absence of compositional drift. The copolymer is produced by polymerization in two continuously-fed reaction zones such that the ratio of sulfonic acid-containing comonomer fed to the first reaction zone to the sulfonic acid-containing comonomer fed to the second reaction zone is within the range of about 55:45 to about 80:20. The resin is characterized by a resistance to irreversible dehydration upon exposure to harsh chemicals and by retention of hydroxide functionality upon aging. A resin composition comprising a copolymer lacking compositional drift is also provided for preparation of an oil and grease barrier coating, an oxidation resistant water soluble package, or a battery separator. | 2011-11-24 |
20110288230 | METHOD FOR PREPARING POLYHYDROXY-URETHANES - The invention relates to a method for preparing polyhydroxy-urethanes without using a compound having an isocyanate function, and from amino compounds and compounds carrying carbonate functions, in particular cyclic carbonate functions. The invention also relates to a method for preparing aqueous or hydro-organic formulations containing polyhydroxy-urethanes, and to the use of said polyhydroxy-urethanes and of said aqueous or hydro-organic formulations. | 2011-11-24 |
20110288231 | RAW-MATERIAL COMPOSITIONS FOR RESIN FOR OPTICAL PART, RESIN FOR OPTICAL PART, AND OPTICAL PART - Provided are a resin composition containing a (meth)acrylate compound (A) having a specific structure and a rigid moiety, and a (meth)acrylate compound (B) having a flexible moiety; a resin composition further containing a silane-based (meth)acrylate compound (C-1), an antioxidant (C-2) or an aliphatic compound (C-3) having a specific structure; and an optical component. A resin for an optical component can be produced from those resin compositions, the resin having excellent transparency, causing no cracks, being stable against heat without causing yellowing, and having a low coefficient of thermal expansion, a low water content, excellent shape stability, with excellent mold releasability, and excellent adhesiveness with a coating material that suppresses surface reflection and improves transmittance. | 2011-11-24 |
20110288232 | LATEX EMULSIONS AND COATING COMPOSITIONS FORMED FROM LATEX EMULSIONS - Latex emulsions are disclosed which can be used in the formation of coating compositions that are not water sensitive, have good blush resistance and retortability. In some embodiments, the coating compositions are used to coat substrates such as cans and packaging materials for the storage of food and beverages. Coating compositions can be prepared by mixing an ethylenically unsaturated monomer component and a stabilizer comprising a strong acid, in a carrier to form a monomer emulsion, reacting the monomer emulsion with an initiator to form the latex emulsion, and reacting the latex emulsion with a neutralizer. Methods of coating substrates with the coating compositions, and substrates coated with the coating compositions are also disclosed. The latex emulsions can be prepared by mixing an ethylenically unsaturated monomer component and a stabilizer comprising a strong acid, in a carrier to form a monomer emulsion, and reacting the monomer emulsion with an initiator to form the latex emulsion, wherein the stabilizer is present in an amount from about 0.1 to about 2.0 by weight polymeric solids. | 2011-11-24 |
20110288233 | CLEARCOAT COMPOSITION FOR USE IN WATERBORNE BASECOAT-CLEARCOAT COMPOSITE COATINGS - A process for forming a color-clear multilayer coating on a substrate is disclosed. The basecoat is a waterborne coating and the clear topcoat is isocyanate containing and comprises a polyene and a polythiol. The isocyanate can be present as a separate component or can be an isocyanate-functional polyene. | 2011-11-24 |
20110288234 | SILICA NANOPARTICLES POSTLOADED WITH PHOTOSENSITIZERS FOR DRUG DELIVERY IN PHOTODYNAMIC THERAPY - A nanoparticle including a polysiloxane base having an exterior surface and having a photosensitizer at least partly exposed at its exterior surface, said photosensitizer being secured to the exterior surface by loading the photosensitizer onto the surface after formation of the polysiloxane base of the nanoparticle. The nanoparticle may have tumor targeting moieties and may be post loaded with cyanine dye. The nanoparticle preferably includes post loaded moieties providing at least two of tumor specificity, photodynamic properties and imaging capabilities and the photosensitizer is tagged with a radioisotope. A method for preparation of the nanoparticle is also provided. | 2011-11-24 |
20110288235 | Process for the Preparation of Pramlintide - The present invention provides for an efficient process for making pramlinitide, as well as novel intermediates for the making of the same. | 2011-11-24 |
20110288236 | RESIN COMPOSITION - The present invention provides a resin composition consisting of a functionalized polypropylene (PP) and a functionalized styrenic thermoplastic elastomer (TPS). The functionalized PP is a PP grafted with N-vinyl pyrrolidone (NVP) and glycidyl methacrylate (GMA), and the functionalized TPS is a TPS grafted with acrylamide or methacrylamide. The functionalized PP and the functionalized TPS are subjected to melt blending to obtain the resin composition with a slight cross-linking structure due to the reaction between GMA and acrylamide or methacrylamide, therefore the resin composition presents good physical properties. Besides, the resin composition without additional plasticizer or other small molecular organic compounds can be utilized in blood bags, blood transfusion and collection apparatuses, etc. Thus, it does not release small molecular substances which are of potential harm to human body during use. | 2011-11-24 |